mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.03 |
mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
0.23 |
0.03 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.03 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |